News
Stay informed with our latest news posts.
The Sun: Gemma Collins' life-changing weight loss journey with Yazen
Gemma Collins reveals her two dress size drop, crediting Yazen’s GLP-1 weight loss injections for helping her achieve a healthier, happier lifestyle.
Mail Online: Gemma Collins about her weight loss journey with Yazen
Gemma Collins reveals her weight loss journey with Yazen’s GLP-1 injections, sharing how it has transformed her health and happiness.
Entertainment Daily: Gemma Collins weight loss with Yazen programme
Gemma Collins has unveiled her stunning weight loss, crediting Yazen’s GLP-1 programme and injections for helping her feel healthier, happier, and free from dieting struggles.
OK: Gemma Collins' weight loss transformation with Yazen
Reality star Gemma Collins reveals her dramatic two dress size drop, crediting Yazen’s GLP-1 weight loss programme with medical injections and personalised support for transforming her health and happiness.
Express: Gemma Collins' weight loss transformation with Yazen jabs
Express: Gemma Collins' weight loss transformation with Yazen jabs
The Mirror: Gemma Collins' weight loss journey with Yazen
Gemma Collins' weight loss journey with Yazen
Yazen expands in Scandinavia through the acquisition of Medstart
Yazen expands in Scandinavia through the acquisition of Danish company Medstart, which is established in Denmark and Norway. Together, they enhance care for people with obesity.
Discover Annie's sustainable weight loss journey with Yazen
Busy mum Annie found sustainable weight loss with Yazen. Four months in, she's healthier, confident, and embracing a positive, lasting lifestyle change.
Sifted UK: Yazen raises €19.5m to expand obesity treatment in the EU
Yazen has secured €19.5 million in Series A funding to expand its GLP-1-based obesity treatment across Europe. The company combines medication with lifestyle support for sustainable weight loss results.
Yazen Health closes €19.5M series A to drive global growth
Yazen Health has successfully closed an oversubscribed €19.5 million series A funding round to fuel its international expansion. This investment enables Yazen to enhance its pioneering obesity treatment model, combining modern weight loss medication with comprehensive lifestyle support.
Lasker~DeBakey Award 2024 for groundbreaking GLP-1 obesity research
Lasker~DeBakey Award 2024 for groundbreaking GLP-1 obesity research
Startups shifting to GLP-1s to tap into $150bn weight loss market
GLP-1 weight loss drugs like Wegovy are attracting startups and investors, aiming to tap into the projected $150bn market despite supply and reimbursement challenges
The urgent need for strict warnings on ultra-processed foods
Four foods that should come with a smoking-style health warning Some scientists believe ultra-processed food needs to be treated in a similar way to tobacco.
Yazen and Dr Martin Carlsson in Health Tech World
Join Health Tech World's webinar with experts discussing sustainable weight loss through medication, lifestyle changes, and digital health tools. Watch now!
WHO: Medical Product Alert: Fake Ozempic (semaglutide)
Medical Product Alert: Fake Ozempic (semaglutide) Detected in Americas and Europe
Popular drug linked to reduced dementia risk in elderly with diabetes
Study shows GLP-1 agonists reduce dementia risk in elderly with type 2 diabetes. Findings from KI highlight potential benefits for diabetes treatment
Dr. Punam Krishan debunks myths surrounding obesity
Dr. Punam Krishan debunks myths surrounding obesity
Wigan named UK's 'Fattest Town' - Yazen Health tackles obesity safely
Wigan named UK's 'Fattest Town' - Yazen Health tackles obesity safely
What care do the morbidly obese individuals need?
The obesity epidemic is one of the greatest health challenges of our time. Globally, it is estimated that 1.9 billion people will suffer from morbid obesity by 2035, which represents one in four adults. Among children, obesity is expected to increase by 100 percent between 2020 and 2035. The cost to society is projected to be 4 trillion dollars.
Yazen participates in roundtable with Health Tech World
Martin Carlsson participates in "Where next for digital health? A roundtable debate hosted by Health Tech World
There are no results with this criteria. Try changing your search.